Baillie Gifford & Co
TMO icon

Baillie Gifford & Co’s Thermo Fisher Scientific TMO Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$205M Sell
504,676
-4,701
-0.9% -$1.91M 0.15% 97
2025
Q1
$253M Sell
509,377
-29,480
-5% -$14.7M 0.22% 76
2024
Q4
$280M Sell
538,857
-64,537
-11% -$33.6M 0.22% 76
2024
Q3
$373M Sell
603,394
-18,122
-3% -$11.2M 0.28% 70
2024
Q2
$344M Sell
621,516
-9,733
-2% -$5.38M 0.27% 72
2024
Q1
$367M Sell
631,249
-39,916
-6% -$23.2M 0.29% 69
2023
Q4
$356M Sell
671,165
-25,769
-4% -$13.7M 0.28% 76
2023
Q3
$353M Sell
696,934
-16,513
-2% -$8.36M 0.32% 69
2023
Q2
$372M Sell
713,447
-480,342
-40% -$251M 0.32% 73
2023
Q1
$688M Sell
1,193,789
-83,105
-7% -$47.9M 0.62% 39
2022
Q4
$703M Sell
1,276,894
-60,833
-5% -$33.5M 0.73% 34
2022
Q3
$678M Sell
1,337,727
-28,448
-2% -$14.4M 0.7% 39
2022
Q2
$742M Sell
1,366,175
-13,145
-1% -$7.14M 0.76% 37
2022
Q1
$815M Sell
1,379,320
-111,772
-7% -$66M 0.57% 47
2021
Q4
$995M Sell
1,491,092
-6,174
-0.4% -$4.12M 0.55% 53
2021
Q3
$855M Sell
1,497,266
-7,024
-0.5% -$4.01M 0.45% 58
2021
Q2
$759M Buy
1,504,290
+49,908
+3% +$25.2M 0.37% 72
2021
Q1
$664M Sell
1,454,382
-727,201
-33% -$332M 0.37% 69
2020
Q4
$1.02B Sell
2,181,583
-56,300
-3% -$26.2M 0.57% 42
2020
Q3
$988M Sell
2,237,883
-28,053
-1% -$12.4M 0.68% 36
2020
Q2
$821M Buy
2,265,936
+61,814
+3% +$22.4M 0.63% 37
2020
Q1
$625M Sell
2,204,122
-17,634
-0.8% -$5M 0.68% 32
2019
Q4
$722M Sell
2,221,756
-75,687
-3% -$24.6M 0.7% 30
2019
Q3
$669M Sell
2,297,443
-57,736
-2% -$16.8M 0.76% 29
2019
Q2
$692M Sell
2,355,179
-3,215
-0.1% -$944K 0.73% 29
2019
Q1
$646M Sell
2,358,394
-11,500
-0.5% -$3.15M 0.71% 33
2018
Q4
$530M Sell
2,369,894
-11,231
-0.5% -$2.51M 0.69% 34
2018
Q3
$581M Buy
2,381,125
+2,935
+0.1% +$716K 0.63% 38
2018
Q2
$493M Sell
2,378,190
-24,757
-1% -$5.13M 0.53% 43
2018
Q1
$496M Sell
2,402,947
-20,071
-0.8% -$4.14M 0.58% 38
2017
Q4
$460M Buy
+2,423,018
New +$460M 0.57% 40